Preoperative Maltodextrin's Effect on Cardiac Function in Cardiac Surgery

Status Not yet recruiting

Clinical Trial Summary

A randomized, controlled, double-blinded clinical trial evaluating the effect of the administration of a Maltodextrin solution on cardiac function in patients presenting for coronary artery bypass grafting surgery with a reduced left ventricular ejection fraction.

Clinical Trial Description

This randomized, double-blinded clinical trial will test the primary hypothesis that patients receiving preoperative maltodextrin will have an improved intraoperative left ventricular ejection fraction (LVEF), as measured by three-dimensional echocardiography, compared to patients who receive a placebo drink. Seventy patients will be recruited and randomized to each group in a 1:1 ratio. The second hypothesis is that administering preoperative Maltodextrin to cardiac surgery patients enhances the quality of recovery, as measured by the Quality of Recovery-15 score. Each patient will undergo this questionnaire 48 hours after surgery. The third hypothesis is that Maltodextrin improves cardiac function by its effect on myocardial glycogen content. This will be evaluated in two ways. First, a separate group of 20 patients will undergo the hyperinsulinemic-normoglycemic clamp (HNC) to have a high-insulin level during surgery with these patients randomized to Maltodextrin or placebo. In addition, 20 patients from the main study will undergo myocardial biopsies to assess the glycogen content in the Maltodextrin and the placebo groups. Pre-defined subgroups: - Need for vasopressors or inotropes during measures of cardiac function vs no need - Male versus female - Diabetic versus non-diabetic - Sarcopenic versus non-sarcopenic - Malnourished versus non-malnourished ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05188222
Study type	Interventional
Source	Jewish General Hospital
Contact	Matthew Cameron, MDCM, MPH
Phone	514-340-8222
Email	matthew.cameron@mcgill.ca
Status	Not yet recruiting
Phase	Phase 4
Start date	September 1, 2024
Completion date	December 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05529654` - IMpella-Protected cArdiaC Surgery Trial (IMPACT)	N/A
Recruiting	`NCT04671966` - Sex Differences in Myocardial Steatosis Induced Left Ventricular Dysfunction	Phase 4
Recruiting	`NCT04950218` - The Psoriasis Echo Study
Completed	`NCT01076920` - Mesenchymal Stem Cells and Myocardial Ischemia	Phase 1/Phase 2
Completed	`NCT01128790` - Pilot Study of Remote Ischemic Preconditioning in Heart Failure	N/A
Completed	`NCT04942353` - Effects of Home-based Exercise Rehabilitation on Healthcare Utilization in HeartMate 3 Patients	N/A
Recruiting	`NCT05769036` - Conventional Biventricular Versus Left Bundle Branch Pacing on Outcomes in Heart Failure Patients	N/A
Completed	`NCT03232736` - InterventiOn of Biventricular Pacemaker Function on ventrIcular Function Among Patients With LVAD's
Recruiting	`NCT04694092` - Landiolol for Rate Control in Decompensated Heart Failure Due to Atrial Fibrillation	N/A
Completed	`NCT01609738` - Left Ventricular Septum Pacing in Patients by Transvenous Approach Through the Inter-ventricular Septum	Phase 1/Phase 2
Completed	`NCT02013037` - The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation	Phase 3
Completed	`NCT00551681` - Effects of Left Ventricular Pacing Optimilization on Cardiac Perfusion, Contractile Force, and Clinical Performance in Patients With Ventricular Dysfunction and Heart Failure	N/A
Not yet recruiting	`NCT04103008` - Left Ventricular Function After Primary Percutaneous Coronary Intervention: Role of Speckle Echocardiography
Completed	`NCT06197256` - Cardiac Dysfunction in Critically Ill Covid-19 Patients
Recruiting	`NCT05860504` - Acute Cardiac Dysfunction in Critical Illnes
Completed	`NCT03787810` - Left Ventricular Dysfunction in Critically Ill Patients
Completed	`NCT01093001` - Tricuspid Regurgitation Study	Phase 4
Active, not recruiting	`NCT00461734` - PROTECT-PACE STUDY - The Protection of Left Ventricular Function During Right Ventricular Pacing	N/A
Recruiting	`NCT04752293` - Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
Not yet recruiting	`NCT05760924` - Left Bundle Branch Pacing on Outcomes and Ventricular Remodeling in Biventricular CRT Nonresponders	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.